Eli Lilly and

Social media sentiment, last 30 days

Average tone of posts mentioning LLY, from −1 (all negative) to +1 (all positive). Latest day: +0.00 across 44 mentions.

• NewsOct 19, 1:53 PM ETVandana Singh

  Swiss Pharma Giant Roche Suspends German Capital Commitments Amid Dispute Over Drug Discounts

• NewsOct 19, 4:44 AM ET

  Eli Lilly’s Omvoh Shows 1-Year Phase 3 Results for Kids with Ulcerative Colitis

• Press releaseOct 19, 4:40 AM ETPRNewswire

  Lilly's Omvoh (mirikizumab-mrkz) meets primary endpoint of clinical remission and is the first IL-23p19 inhibitor to report one-year Phase 3 results in pediatric ulcerative colitis

• Press releaseOct 18, 6:05 PM ETPRNewswire

  Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress

• NewsOct 17, 2:22 AM ETMohd Haider

  JD Vance Touts TrumpRx Drug Price Push, Trump Accounts as ‘Economic Nationalism’ Wins Ahead Of Midterms

• NewsOct 16, 11:04 AM ETVandana Singh

  Eli Lilly's GLP-1 Pill Wins Key European Backing for Obesity and Diabetes

• NewsOct 15, 11:51 AM ETVandana Singh

  Eli Lilly Says New Drug Drives Comprehensive Disease Control in Ulcerative Colitis Patients

• Press releaseOct 15, 10:00 AM ETPRNewswire

  Lilly confirms date and conference call for third-quarter 2026 financial results announcement

• Press releaseOct 15, 8:00 AM ETPRNewswire

  New composite outcomes data show patients treated with Lilly's Omvoh (mirikizumab-mrkz) achieved comprehensive corticosteroid-free disease control in ulcerative colitis and corticosteroid-free deep remission in Crohn's disease at one year

• Press releaseOct 14, 1:39 PM ETPRNewswire

  Nasdaq Sheds 1.65% as Russell 2000 Sinks to RSI 28, Oil Climbs While Gold and Silver Slide

• NewsOct 14, 11:39 AM ETPiero Cingari

  Nasdaq 100 Drops 1% on Hot CPI, SOXX Falls 7th Day: Stock Market Today

• Press releaseOct 14, 4:07 AM ETPRNewswire

  Cancer Drug Spending Is Headed Past $400 Billion as Colorectal and Pancreatic Cancers Move Up the Research Agenda

• NewsOct 13, 9:16 AM ET

  U.K. Medicines And Healthcare Products Regulatory Agency Authorizes Eli Lilly's Onswik For Adults With Type 2 Diabetes

• NewsOct 13, 7:22 AM ET

  Prelude Therapeutics Enters Clinical Trial Collaboration And Supply Agreement With Eli Lilly For Supply Of Its CDK4/6 Kinase Inhibitor, Abemaciclib And Its Oral Estrogen Receptor Antagonist Imlunestrant

• NewsOct 12, 5:12 AM ETAnanya Gairola

  Stephen King Slams Trump’s New Press Secretary as Past Vaccine Conspiracy Theories, Third-Term Posts Spark Fresh Controversy: 'She Appears to Have Tried to…'

• Press releaseOct 9, 1:30 PM ETPRNewswire

  Record Highs Beckon for Big Caps as Small Caps Lag and Deal Flow Builds

• Press releaseOct 9, 6:45 AM ETPRNewswire

  New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) advance understanding of the interconnected immune and metabolic biology in adults with psoriasis and obesity

• NewsOct 8, 1:19 PM ETPiero Cingari

  Stock Market Today: S&P 500 Slips as Oil Spikes 5%, 10-Year Yields Near 5.35%

• NewsOct 8, 11:25 AM ET

  Transcript: Eli Lilly Q2 2026 Earnings Conference Call

• NewsOct 8, 6:35 AM ETMohd Haider

  Pharma Lobby Sues Trump Administration Over Medicare Drug Pricing Rule, Calls It ‘Unlawful Overreach’ — ‘The Results Are Preordained’

• NewsOct 8, 3:50 AM ETAvi Kapoor

  Dow Falls Over 300 Points As Treasury Yields Surge: Investor Sentiment Weakens, Fear & Greed Index Remains In ‘Neutral’ Zone

• Press releaseOct 7, 2:14 PM ETPRNewswire

  Nasdaq and S&P Hold Weekly Gains as Small Caps and Dow Slip Midweek

• NewsOct 7, 12:53 PM ETPiero Cingari

  Stock Market Today: S&P 500, Russell 2000 Fall as 30-Year Yield Hits 5.7%

• NewsOct 6, 11:46 AM ETChandrima Sanyal

  Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up

• Press releaseOct 6, 9:06 AM ETGlobe Newswire

  Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.

• Press releaseOct 5, 2:28 PM ETPRNewswire

  Nasdaq Hits Fresh Highs While Dow Slips and Small Caps Struggle for Direction

• NewsOct 5, 9:34 AM ETVandana Singh

  FDA Expands Approval for Eli Lilly Therapy in Untreated Leukemia Patients

• Press releaseOct 5, 7:50 AM ETPRNewswire

  Lilly to present new data across its dermatology portfolio with 21 presentations at Fall Clinical 2026, in pursuit of advancing care for chronic skin conditions

• Press releaseOct 2, 3:05 PM ETPRNewswire

  Lilly's Jaypirca (pirtobrutinib), the first-and-only approved non-covalent BTK inhibitor, receives expanded indication from U.S. FDA for certain patients with previously untreated CLL/SLL

• NewsOct 1, 1:03 PM ETVandana Singh

  Eli Lilly's Once-Daily Weight Loss Pill Orforglipron Shows Significant Reduction in Heart Disease Risk

• NewsOct 1, 12:17 PM ETVandana Singh

  Foghorn Therapeutics Pivots Pipeline after Ending Eli Lilly Deal

• Press releaseOct 1, 12:11 PM ETPRNewswire

  AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment

• Press releaseOct 1, 7:00 AM ETPRNewswire

  Lilly's oral GLP-1, Foundayo (orforglipron), was associated with significant reductions in predicted long-term risk of type 2 diabetes and cardiovascular disease

• NewsOct 1, 6:17 AM ETSnigdha Gairola

  Chuck Schumer Slams Hyde Amendment on 50th Anniversary, Says Abortion Restrictions Force Americans to Choose Between Care, Rent, Food: ‘Health Care Must Not Be a Privilege’

• Press releaseSep 30, 6:00 PM ETPRNewswire

  Lilly's oral GLP-1, Foundayo (orforglipron), demonstrated cardiovascular safety alongside sustained A1C reduction and weight loss in its largest and longest type 2 diabetes study

• NewsSep 29, 1:11 PM ETNeeraj Jain

  Weight Watchers Expands GLP-1 Era Strategy With Google Health

• NewsSep 28, 9:01 AM ETRishabh Mishra

  Stock Market Today: S&P 500, Dow, Nasdaq 100 Futures Fall as Rising Yields and Trump's Rejection of Hormuz Deal Spook Investors — LLY, PEP, JEF in Focus (UPDATED)

• NewsSep 24, 1:32 PM ETPiero Cingari

  S&P 500 Erases Losses as US, Iran Reportedly Discuss Hormuz Deal: Stock Market Today

• NewsSep 22, 8:28 AM ETVandana Singh

  Trump's Drug Price Achievements Questioned Following Separate Most Favored Nation Contract Disclosures with Lilly, Pfizer

• NewsSep 21, 9:13 AM ETVandana Singh

  Beyond Ozempic: Novo Nordisk Plots Next Decade Growth with Bigger Pipeline, Slimmer Workforce

• NewsSep 15, 9:29 AM ETHenry Khederian

  Eli Lilly Stock Gains as Retatrutide and Foundayo Data Highlight Pipeline Strength

• Press releaseAug 5, 6:45 AM ETPRNewswire

  Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress

• NewsAug 4, 8:09 AM ETAvi Kapoor

  How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q2 Earnings

• NewsApr 30, 11:27 AM ET

  Eli Lilly Q1 2026 Earnings Call Transcript

• Press releaseApr 30, 6:45 AM ETPRNewswire

  Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines

• NewsApr 24, 2:27 PM ETCaroline Ryan

  Deal Dispatch: QXO Nabs TopBuild For $17 Million, Voya Financial Urged To Evaluate Strategic Options, Pat McGrath Exits Chapter 11

• NewsFeb 5, 1:00 PM ET

  P/E Ratio Insights for Eli Lilly and Co

• NewsFeb 4, 12:32 PM ETAvi Kapoor

  Nasdaq Dips Over 400 Points; Eli Lilly Shares Surge Following Upbeat Earnings

• NewsFeb 4, 12:29 PM ETAlex Perry

  Eli Lilly Q4 2025 Earnings Call Transcript

• Press releaseFeb 4, 6:45 AM ETPRNewswire

  Lilly reports fourth-quarter 2025 financial results and provides 2026 guidance